Matinas BioPharma Announces Results From An Additional In Vivo Study In Healthy Mice With An Oral LNC Formulation Of Docetaxel, A Chemotherapeutic Agent Used In The Management Of Multiple Metastatic And Unresectable Tumors
Matinas BioPharma公佈了另一項針對健康小鼠的體內研究結果,該小鼠採用口服LNC配方多西他賽,多西他賽是一種用於治療多種轉移性和不可切除腫瘤的化療藥物